Role of Experience With Preventive Medication and Personal Risk Attitude in Non-Attendance at Triple Vascular Screening

Tina B. Hansen; Jes S. Lindholt; Rikke Søgaard

doi:10.1016/j.ejvs.2018.04.016

Role of Experience With Preventive Medication and Personal Risk Attitude in Non-Attendance at Triple Vascular Screening

Tina B. Hansen^*, Jes S. Lindholt, Rikke Søgaard

^*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

BACKGROUND: Non-attendance for vascular screening potentially restricts the overall benefit of screening at population level, but may be the result of rational judgment on the part of invitees who might not consider their risk to be relevant. The aim of this study was to investigate the role of current use of preventive medication and personal risk attitude as potential factors explaining non-attendance at triple vascular screening.

METHODS: This was a case control study across 25,078 men offered screening and intervention for abdominal aortic aneurysm, peripheral artery disease, and hypertension in the Viborg Vascular (VIVA) screening trial. Data on socio-demographic and socio-economic characteristics, diagnoses, and use of preventive medication were extracted from national registries. A proxy for personal risk attitude was constructed. Logistic regression was used to estimate odds ratios with 95% confidence intervals.

RESULTS: Use of statins (0.78; 95% CI 0.71-0.85), antihypertensives (1.26, 95% CI 1.13-1.41), or antithrombotics (1.13, 95% CI 1.04-1.23) were all associated with non-attendance. With regards to personal risk attitude, a statistically significant association was found between users of preventive medication with no recent diagnosis of cardiovascular disease and non-attendance (0.82, 95% CI 0.72-0.94). The role of traditional factors explaining non-attendance at vascular screening, such as low socio-economic status and comorbidity, was confirmed.

CONCLUSION: Non-attendance at triple vascular screening is influenced by use of preventive medications and traditional explanatory factors of non-attendance at vascular screening, including existing CVD comorbidity. Attendance rates might benefit from rethinking risk communication alongside screening invitations according to varying invitee profiles and clinical risk scenarios, and from providing interventions targeted at individuals with lower levels of health literacy.

Original language	English
Journal	European Journal of Vascular and Endovascular Surgery
Volume	56
Issue number	2
Pages (from-to)	282-290
ISSN	1078-5884
DOIs	https://doi.org/10.1016/j.ejvs.2018.04.016
Publication status	Published - Aug 2018

Keywords

Aortic aneurysm
Hypertension
Mass screening
Peripheral arterial disease
Secondary prevention
Vascular disease
Predictive Value of Tests
Humans
Fibrinolytic Agents/therapeutic use
Male
Case-Control Studies
Hypertension/diagnosis
Registries
Odds Ratio
Antihypertensive Agents/therapeutic use
Primary Prevention/methods
Risk Assessment
Risk Factors
Logistic Models
Treatment Outcome
Health Knowledge, Attitudes, Practice
Randomized Controlled Trials as Topic
Denmark/epidemiology
Peripheral Arterial Disease/diagnosis
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use
Aged
Aortic Aneurysm, Abdominal/diagnostic imaging
Patient Compliance
Mass Screening/methods

Documents & Links

10.1016/j.ejvs.2018.04.016

Cite this

@article{76c8ee63d26245b28ea68b14526f9b2f,

title = "Role of Experience With Preventive Medication and Personal Risk Attitude in Non-Attendance at Triple Vascular Screening",

abstract = "BACKGROUND: Non-attendance for vascular screening potentially restricts the overall benefit of screening at population level, but may be the result of rational judgment on the part of invitees who might not consider their risk to be relevant. The aim of this study was to investigate the role of current use of preventive medication and personal risk attitude as potential factors explaining non-attendance at triple vascular screening.METHODS: This was a case control study across 25,078 men offered screening and intervention for abdominal aortic aneurysm, peripheral artery disease, and hypertension in the Viborg Vascular (VIVA) screening trial. Data on socio-demographic and socio-economic characteristics, diagnoses, and use of preventive medication were extracted from national registries. A proxy for personal risk attitude was constructed. Logistic regression was used to estimate odds ratios with 95% confidence intervals.RESULTS: Use of statins (0.78; 95% CI 0.71-0.85), antihypertensives (1.26, 95% CI 1.13-1.41), or antithrombotics (1.13, 95% CI 1.04-1.23) were all associated with non-attendance. With regards to personal risk attitude, a statistically significant association was found between users of preventive medication with no recent diagnosis of cardiovascular disease and non-attendance (0.82, 95% CI 0.72-0.94). The role of traditional factors explaining non-attendance at vascular screening, such as low socio-economic status and comorbidity, was confirmed.CONCLUSION: Non-attendance at triple vascular screening is influenced by use of preventive medications and traditional explanatory factors of non-attendance at vascular screening, including existing CVD comorbidity. Attendance rates might benefit from rethinking risk communication alongside screening invitations according to varying invitee profiles and clinical risk scenarios, and from providing interventions targeted at individuals with lower levels of health literacy.",

keywords = "Aortic aneurysm, Hypertension, Mass screening, Peripheral arterial disease, Secondary prevention, Vascular disease, Predictive Value of Tests, Humans, Fibrinolytic Agents/therapeutic use, Male, Case-Control Studies, Hypertension/diagnosis, Registries, Odds Ratio, Antihypertensive Agents/therapeutic use, Primary Prevention/methods, Risk Assessment, Risk Factors, Logistic Models, Treatment Outcome, Health Knowledge, Attitudes, Practice, Randomized Controlled Trials as Topic, Denmark/epidemiology, Peripheral Arterial Disease/diagnosis, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Aged, Aortic Aneurysm, Abdominal/diagnostic imaging, Patient Compliance, Mass Screening/methods",

author = "Hansen, {Tina B.} and Lindholt, {Jes S.} and Rikke S{\o}gaard",

year = "2018",

month = aug,

doi = "10.1016/j.ejvs.2018.04.016",

language = "English",

volume = "56",

pages = "282--290",

journal = "European Journal of Vascular and Endovascular Surgery",

issn = "1078-5884",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Role of Experience With Preventive Medication and Personal Risk Attitude in Non-Attendance at Triple Vascular Screening

AU - Hansen, Tina B.

AU - Lindholt, Jes S.

AU - Søgaard, Rikke

PY - 2018/8

Y1 - 2018/8

N2 - BACKGROUND: Non-attendance for vascular screening potentially restricts the overall benefit of screening at population level, but may be the result of rational judgment on the part of invitees who might not consider their risk to be relevant. The aim of this study was to investigate the role of current use of preventive medication and personal risk attitude as potential factors explaining non-attendance at triple vascular screening.METHODS: This was a case control study across 25,078 men offered screening and intervention for abdominal aortic aneurysm, peripheral artery disease, and hypertension in the Viborg Vascular (VIVA) screening trial. Data on socio-demographic and socio-economic characteristics, diagnoses, and use of preventive medication were extracted from national registries. A proxy for personal risk attitude was constructed. Logistic regression was used to estimate odds ratios with 95% confidence intervals.RESULTS: Use of statins (0.78; 95% CI 0.71-0.85), antihypertensives (1.26, 95% CI 1.13-1.41), or antithrombotics (1.13, 95% CI 1.04-1.23) were all associated with non-attendance. With regards to personal risk attitude, a statistically significant association was found between users of preventive medication with no recent diagnosis of cardiovascular disease and non-attendance (0.82, 95% CI 0.72-0.94). The role of traditional factors explaining non-attendance at vascular screening, such as low socio-economic status and comorbidity, was confirmed.CONCLUSION: Non-attendance at triple vascular screening is influenced by use of preventive medications and traditional explanatory factors of non-attendance at vascular screening, including existing CVD comorbidity. Attendance rates might benefit from rethinking risk communication alongside screening invitations according to varying invitee profiles and clinical risk scenarios, and from providing interventions targeted at individuals with lower levels of health literacy.

AB - BACKGROUND: Non-attendance for vascular screening potentially restricts the overall benefit of screening at population level, but may be the result of rational judgment on the part of invitees who might not consider their risk to be relevant. The aim of this study was to investigate the role of current use of preventive medication and personal risk attitude as potential factors explaining non-attendance at triple vascular screening.METHODS: This was a case control study across 25,078 men offered screening and intervention for abdominal aortic aneurysm, peripheral artery disease, and hypertension in the Viborg Vascular (VIVA) screening trial. Data on socio-demographic and socio-economic characteristics, diagnoses, and use of preventive medication were extracted from national registries. A proxy for personal risk attitude was constructed. Logistic regression was used to estimate odds ratios with 95% confidence intervals.RESULTS: Use of statins (0.78; 95% CI 0.71-0.85), antihypertensives (1.26, 95% CI 1.13-1.41), or antithrombotics (1.13, 95% CI 1.04-1.23) were all associated with non-attendance. With regards to personal risk attitude, a statistically significant association was found between users of preventive medication with no recent diagnosis of cardiovascular disease and non-attendance (0.82, 95% CI 0.72-0.94). The role of traditional factors explaining non-attendance at vascular screening, such as low socio-economic status and comorbidity, was confirmed.CONCLUSION: Non-attendance at triple vascular screening is influenced by use of preventive medications and traditional explanatory factors of non-attendance at vascular screening, including existing CVD comorbidity. Attendance rates might benefit from rethinking risk communication alongside screening invitations according to varying invitee profiles and clinical risk scenarios, and from providing interventions targeted at individuals with lower levels of health literacy.

KW - Aortic aneurysm

KW - Hypertension

KW - Mass screening

KW - Peripheral arterial disease

KW - Secondary prevention

KW - Vascular disease

KW - Predictive Value of Tests

KW - Humans

KW - Fibrinolytic Agents/therapeutic use

KW - Male

KW - Case-Control Studies

KW - Hypertension/diagnosis

KW - Registries

KW - Odds Ratio

KW - Antihypertensive Agents/therapeutic use

KW - Primary Prevention/methods

KW - Risk Assessment

KW - Risk Factors

KW - Logistic Models

KW - Treatment Outcome

KW - Health Knowledge, Attitudes, Practice

KW - Randomized Controlled Trials as Topic

KW - Denmark/epidemiology

KW - Peripheral Arterial Disease/diagnosis

KW - Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use

KW - Aged

KW - Aortic Aneurysm, Abdominal/diagnostic imaging

KW - Patient Compliance

KW - Mass Screening/methods

U2 - 10.1016/j.ejvs.2018.04.016

DO - 10.1016/j.ejvs.2018.04.016

M3 - Journal article

C2 - 29891436

AN - SCOPUS:85048192330

SN - 1078-5884

VL - 56

SP - 282

EP - 290

JO - European Journal of Vascular and Endovascular Surgery

JF - European Journal of Vascular and Endovascular Surgery

IS - 2

ER -

Role of Experience With Preventive Medication and Personal Risk Attitude in Non-Attendance at Triple Vascular Screening

Abstract

Keywords

Documents & Links

Fingerprint

Cite this